Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Frequently Asked Questions
Frequently Asked Questions
Communities & Collections
Communities & Collections
Could Individuals From Countries Using BCG Vaccination Be Resistant to SARS-COV-2 Induced Infections?
Date
2020-01-01
Author
Ayanoğlu, İhsan Cihan
İpekoğlu, Emre Mert
Yazar, Volkan
Yilmaz, Ismail Cem
Gürsel, Mayda
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
10
views
0
downloads
The lower than expected number of SARS-CoV-2 cases in countries with fragile health systems is puzzling. Herein, we hypothesize that BCG vaccination policies and vaccine strain preferences adopted by different countries might influence the SARS-CoV-2 transmission patterns and/or COVID-19 associated morbidity and mortality. We also postulate that until a specific vaccine is developed, SARS-CoV-2 vulnerable populations could be immunized with BCG vaccines to attain heterologous nonspecific protection from the new coronavirus. In the lights of our investigations the most resistant countries appear to be the ones using Group I BCG strain. Within these countries, however, those who employs Russian strain is even more protected against COVID-19 infection.
Subject Keywords
BCG
,
COVID-19
,
SARS-CoV-2 infections
,
Protection
URI
https://hdl.handle.net/11511/47379
Journal
TURKISH JOURNAL OF IMMUNOLOGY
DOI
https://doi.org/10.25002/tji.2020.1250
Collections
Department of Biology, Article